AHA 2023 As discussant of the SELECT trial, Ania Jastreboff reviews the results. She points out that it is critical to treat obesity. Not only to achieve weight reduction, but also to improve health outcomes.
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Improvement in health outcomes with GLP-1RA in patients with overweight or obesity with CVD
Improvement in health outcomes with GLP-1RA in patients with overweight or obesity with CVD
closeAHA 2023 As discussant of the SELECT trial, Ania Jastreboff reviews the results. She points out that it is critical to treat obesity. Not only to achieve weight reduction, but also to improve health outcomes.
This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, USA.
Ania Jastreboff, MD, PhD is an Associate Professor in Medicine and Pediatrics at Yale School of Medicine in New Haven, CT, USA. She is the director of the Yale Obesity Research Center and co-director of the Yale Center for Weight Management.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read a summary of the SELECT trial
AHA 2023 As discussant of the SELECT trial, Ania Jastreboff reviews the results. She points out that it is critical to treat obesity. Not only to achieve weight reduction, but also to improve health outcomes.
This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, USA.
Ania Jastreboff, MD, PhD is an Associate Professor in Medicine and Pediatrics at Yale School of Medicine in New Haven, CT, USA. She is the director of the Yale Obesity Research Center and co-director of the Yale Center for Weight Management.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read a summary of the SELECT trial
Stay current with the best on medical education
Facebook Comments